Why I love a free lunchBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39556.557234.94 (Published 24 April 2008) Cite this as: BMJ 2008;336:962
- Kinesh Patel, junior doctor, London
Who’s ever heard of ivabradine? Who even knows how to pronounce it?
In a nutshell it’s a newish negatively chronotropic drug used to manage stable angina in patients who don’t tolerate ß blockers. I certainly had never heard of it until a leaflet was handed to me by a smiling drug company representative at a sponsored lunch before a hospital grand round.
I know it’s not politically correct to say this, but I quite enjoy a free lunch, especially when it comes from Marks & Spencer. Judging by the number …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial